U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415135) titled 'Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy' on Feb. 03.
Brief Summary: This study is a single-center, single-arm, open-label exploratory study to evaluate the safety and efficacy of fluorescent imaging combined with a robotic surgical control system for robot-assisted radical prostatectomy.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
DRUG: 0.02 mg/kg of DGPR1008 Injection was administered 24 hours before surgery
0.02 mg/kg
DRUG: 0.04 mg/kg of DGPR1008 Injection was administered 2...